NCT00013702View on ClinicalTrials.gov

Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

February 29, 2004

Conditions
Hepatitis BHIV Infection
Interventions
DRUG

Adefovir

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00013702 - Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients | Biotech Hunter | Biotech Hunter